054950 — JVM Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSuper Stock

Annual income statement for JVM Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	115,411	115,826	141,978	157,085	159,434
Cost of Revenue
Gross Profit	41,983	39,249	51,157	62,595	63,725
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	102,247	104,652	122,002	127,315	128,759
Operating Profit	13,164	11,175	19,975	29,771	30,675
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	12,619	9,404	21,279	33,105	34,692
Provision for Income Taxes
Net Income After Taxes	10,442	8,951	15,756	26,244	28,844
Net Income Before Extraordinary Items
Net Income	10,442	8,951	15,756	26,244	28,844
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	10,442	8,951	15,756	26,244	28,844
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,088	1,065	1,498	2,279	2,506
Dividends per Share